Cellebrite DI Ltd.: management transactions · United States · SEC (Form 4)

About Cellebrite DI Ltd.

Cellebrite DI Ltd. is a specialized digital intelligence software and services company listed on the NASDAQ under the ticker CLBT and operating as a U.S.-listed business with a dual operational footprint in Tysons Corner, Virginia, and Petah Tikva, Israel. For investors, it is best viewed as a technology company positioned at the intersection of cybersecurity, digital forensics and data analytics, serving both public-sector and enterprise customers. The company was founded in 1999 and has built its brand around tools that help investigators collect, process and analyze data from mobile devices, computers and cloud environments in order to accelerate case resolution and support evidence-based decision-making. ([cellebrite.com](https://cellebrite.com/en/about/?utm_source=openai)) Over time, Cellebrite has evolved from a pure digital forensics specialist into a broader “case-to-closure” platform provider. Its portfolio now spans evidence extraction, review, analysis and investigative collaboration, with Inseyets positioned as its flagship digital forensics offering. The company has also been investing in cloud and SaaS capabilities, and its 2025 acquisition of Corellium added Arm-based virtualization expertise, strengthening its technology stack and expanding its ability to support mobile research, security testing and advanced investigative workflows. ([investors.cellebrite.com](https://investors.cellebrite.com/news-releases/news-release-details/cellebrite-completes-acquisition-corellium-extending-industrys?utm_source=openai)) From a competitive standpoint, Cellebrite appears to benefit from meaningful installed-base advantages and deep institutional relationships. The company states that its technology has been purchased by approximately 6,900 public safety agencies and enterprises in more than 100 countries, with broad penetration across North American federal, state and local agencies as well as enterprise blue-chip accounts. That said, the business remains exposed to procurement cycles, regulatory scrutiny and compliance requirements, all of which are especially important in a market tied to law enforcement, national security and public-sector contracting. ([cellebrite.com](https://cellebrite.com/en/about/?utm_source=openai)) Recent developments have been constructive. In 2025 and early 2026, Cellebrite reported continued ARR and revenue growth, highlighted stronger adoption of its cloud and SaaS offerings, and introduced new seasonal releases for its digital investigation platform. The company also established Cellebrite Federal Solutions to better serve the U.S. federal government and said its Government Cloud achieved FedRAMP High authorization, which is an important credibility marker in federal procurement. For equity investors, the name offers a mix of recurring software economics, secular demand for investigative technology and ongoing product expansion, though budget timing and policy-sensitive public-sector spending remain key variables. ([investors.cellebrite.com](https://investors.cellebrite.com/news-releases/news-release-details/cellebrite-announces-record-fourth-quarter-and-full-year-2025?utm_source=openai))